{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Invivyd, Inc."},"Symbol":{"label":"Symbol","value":"IVVD"},"Address":{"label":"Address","value":"1601 TRAPELO ROAD,SUITE 178, WALTHAM, Massachusetts, 02451, United States"},"Phone":{"label":"Phone","value":"+1 781 819-0080"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Invivyd Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's lead product candidate, ADG20 is developed for the treatment and prevention of coronavirus disease which has demonstrated clinically meaningful results in global Phase 3 clinical trials against multiple variants of concern for the prevention and treatment of COVID-19."},"CompanyUrl":{"label":"Company Url","value":"https://www.invivyd.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Robert D. Allen","title":"Chief Scientific Officer"},{"name":"Stacy Price","title":"Chief Technology & Manufacturing Officer"},{"name":"William E. Duke","title":"Chief Executive, Financial & Accounting Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}